, we identify a range of short and non-ATG-initiated ORFs that can generate stable and spatially distinct proteins. Notably, we show that the translation of a new ORF 'hidden' within the long non-coding RNA Aw112010 is essential for the orchestration of mucosal immunity during both bacterial infection and colitis. This work expands our interpretation of the protein-coding genome and demonstrates that proteinaceous products generated from noncanonical ORFs are crucial for the immune response in vivo. We therefore propose that the misannotation of non-canonical ORFcontaining genes as non-coding RNAs may obscure the essential role of a multitude of previously undiscovered protein-coding genes in immunity and disease.
Fig. 1 | Bacterial infection drives widespread ribosomal association with non-coding RNAs. a-f, BMDMs from RiboTag
LysM mice were non-treated (NT) or stimulated with LPS (1 ng ml −1 ). RNA was subjected to RNA-seq. Data are presented as a combination of two independent biological replicates. a, Circos plot shows differentially expressed ribosome-associated transcripts after 6 and 24 h LPS stimulation. Red denotes upregulation; blue denotes downregulation. Each track from the periphery to the core represents: chromosomes location; 12,820 known protein-coding transcripts; 1,176 lncRNAs; 1,107 pseudogenes; and 413 other non-coding RNAs. b, Pie chart of the percentage breakdown of protein-coding genes annotated from RiboTag RNA-seq (fragments per kilobase of transcript per million mapped reads (FPKM) ≥ 1). c, The non-protein coding genes in b are further classified. d, Stratification of detectable BMDM lncRNAs based on ribosome association. Ribosome-associated lncRNAs with an FPKM of ≥ 1 in RiboTag RNA-seq are represented in the red exploded section. Blue section depicts lncRNAs not found in RiboTag RNA-seq, but with an FPKM of ≥ 0.01 in conventional RNA-seq. e, f, Volcano plot (e) and heat map analysis (f) of lncRNAs associated with ribosomes after LPS stimulation in BMDMs. g, qPCR analysis of ribosome-associated transcripts of non-treated BMDMs or those stimulated with LPS (10 ng ml −1 ) or infected with S. Typhimurium at a multiplicity of infection (MOI) of 1 for 6 h. Data are presented as six biological replicates, and fold expression was calculated from each individual non-treated sample. h, RiboTag LysM mice were gavaged with 2 × 10 8 CFUs of S. Typhimurium. After 24 h, colonic tissue was extracted and lysed. Macrophage ribosome-associated RNA was isolated and qPCR analysis was conducted. Data are presented as seven biological replicates. Data are mean and s.e.m.**P < 0.01, ***P < 0.001, ****P < 0.0001, unpaired two-tailed t-test. 
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Immunoprecipitation using haemagglutinin-conjugated magnetic beads and subsequent RNA isolation yielded high-quality RNA from BMDMs from RiboTag LysM mice and no detectable ribosome-associated RNA in wild-type cells (Extended Data Fig. 1a, b) . RiboTag RNA sequencing (RNA-seq) revealed widespread differential ribosome assembly on both protein-coding RNAs and, unexpectedly, on transcripts mapping to 'non-coding' RNAs [8] [9] [10] (Fig. 1a) . In fact, almost 10% of all ribosome-associated RNAs were annotated as 'non-coding' , with pseudogenes and long non-coding RNAs (lncRNAs) representing the most abundant classes (Fig. 1b, c ). lncRNAs have been described to have major functions in diverse biological systems, including immune cell development and function 11, 12 . According to canonical ORF designations, lncRNAs are unable to code for protein 11, 12 ; however, we found that more than 35% of highly expressed macrophage lncRNAs interact with ribosomes during bacterial infection (Fig. 1d) . To identify potentially important protein-coding lncRNAs in the innate immune response, we identified genes that were markedly altered after LPS stimulation (Fig. 1e, f) . We confirmed ribosome association with candidate lncRNAs in RiboTag LysM BMDMs stimulated with LPS or infected with Salmonella enterica serovar Typhimurium (S. Typhimurium) using quantitative PCR (qPCR). Both LPS stimulation and S. Typhimurium infection induced differential ribosome association and transcription of these genes ( Fig. 1g and Extended Data Fig. 1c) . Finally, we infected RiboTag LysM mice with S. Typhimurium and isolated ribosome-associated RNA from colonic macrophages 24 h after bacterial gavage. qPCR analysis revealed significant increases in ribosome-association for the lncRNAs Aw112010 and GM9895 after infection (Fig. 1h) .
Although RiboTag RNA-seq reveals widespread association of lncRNAs with ribosomes during bacterial infection, ribosome association per se does not necessarily indicate whether a given RNA is being actively translated 13 . Ribosome-profiling techniques have emerged as powerful tools to address such caveats 14 . Using steady-state and LPSstimulated wild-type BMDMs, we generated genome-wide ribosome profiles in tandem with conventional poly(A) + RNA-seq. This allowed the successful discrimination of the known protein-coding genes and non-coding RNAs (Extended Data Fig. 2a, b) . Notably, however, we also identified a plethora of lncRNAs with distinct ribosome profiles that were similar to that of known protein-coding genes (Extended Data Fig. 2c ). We next sought to identify actively translated ORFs in an unbiased manner and conducted RibORF analysis 15 . RibORF correctly identified transcripts undergoing active translation (Extended Data  Fig. 2d ). During the classical annotation of the genome, protein-coding genes were accurately identified by the presence of an ATG methionine start codon and an ORF of greater than 300 nucleotides 16, 17 . However, proteinaceous products with as few as 11 amino acids 18 and single nucleotide promiscuity in near cognate ATG codons that facilitate translation initiation 19 have been reported. Using a custom ORFfinder search to identify all ORFs that were more than 30 nucleotides long using the start codons ATG, CTG, TTG or GTG 20 , we generated a library of all potential non-canonical ORFs within BMDM-expressed lncRNAs. RibORF analysis identified 224 non-canonical ORFs with the same translation hallmarks (percentage of maximum entropy (PME) ≥ 0.6; ref. 21 ) as protein-coding genes, and predicted that they undergo active translation (Fig. 2a) . In addition, we wished to identify ORFs using a method that does not require the ORF to be initially a-e, Wild-type BMDMs were non-treated or stimulated with LPS (10 ng ml −1 ) for 6 h and ribosome profiling was conducted. Data are representative of two biological replicates. a, PME values for protein-coding genes and lncRNAs. A PME cut-off value of ≥0.6% represents transcripts considered to be protein coding. b, Translation efficiency (TE) and RRS analysis was conducted on transcripts identified by RiboProfiling. Purple broken lines represent the 95th percentile of the 3ʹ UTRs of known protein-coding genes and discriminates coding and non-coding transcripts. c, d, Categorization of start codon usage (c) and ORF size (d) in RibORF-and/or RiboCodeidentified lncRNAs with coding RRS and translation efficiency values. e, Heat map of the top differentially regulated LPS-stimulated lncRNA ORFs. f, HEK293 cells transfected with empty vector (EV) or
Aw112010
Flag ORF. Cells were stained with DAPI, phalloidin and antiFlag. Scale bars, 9 μ m; original magnifications, × 60 and × 100. g, Wildtype (WT) and Aw112010
HA BMDMs were non-treated or stimulated with LPS (10 ng ml −1 ), protein lysates were generated and western blot analysis was conducted for haemagglutinin and β-tubulin. Data are representative of three biological replicates. h, Aw112010
HA BMDMs were generated, stimulated with LPS for 6 h and subjected to haemagglutinin immunoprecipitation. Purified lysates were subject to mass spectrometry analysis. Precursor ion peaks in the MS1 extracted ion chromatogram corresponding to a spiked in synthetic isotopically labelled peptide standard (top) and co-elution of a peak consistent with the endogenous Aw112010 peptide (bottom) in the same sample. Identified fragment ions (b and y ions, red) are indicated above and below the peptide sequence. Data are representative of two biological replicates. (2) y (12) y (12) y(3) a (2) y (1) b(11) y (9) b (9) b (11) y(10) y(4) y (2) b(13) y (11) b (3) y (8) y ( (2) y (12) a (2) a (3) b (9) y (3) y (2) y (11) y (12) a (11) a (13) a (4) y(10) b(10) a(9) y(8) y* (4) y (5) y (7) a (6) y ( Letter reSeArCH defined with ORFfinder. RiboCode analysis 22 identified 85 noncanonical ORFs within lncRNAs de novo (Extended Data Fig. 3a) . As previously reported 22 , RibORF and RiboCode analyses identify both similar and unique ORFs (Extended Data Fig. 3b ). To investigate the translational veracity of these ORFs further, we conducted another analytical strategy previously used to challenge the assertion that lncRNAs can encode translated proteins. Using translational efficiency 4 and ribosome release score (RRS) analysis to both the 3ʹ untranslated regions (UTRs) and the known protein-coding ORF within these genes, we generated a frame of reference for macrophage-translated and non-translated transcripts. Using the ninety-fifth percentiles of the 3ʹ UTR translational efficiency and RRS, we can predict the ability of a given ORF to encode a translated protein (Fig. 2b) . By selecting non-canonical ORFs identified by RibORF and RiboCode analysis, we identified 96 lncRNAs that share the RRS and translational efficiency values with those of the known protein-coding genome. Nearly half of these ORFs use the ATG start codon, whereas the remaining ORFs shared a relatively even distribution of start codon usage between TTG, GTG and CTG (Fig. 2c) . Most are small ORFs that are under 300 nucleotides in length (Fig. 2d) . To identify putative ORFs than can encode functionally important proteins in the immune response, we performed differential gene expression analysis on these non-canonical ORFs in LPS-stimulated macrophages from the ribosome-profiling sequencing dataset ( Fig. 2e and Extended Data Fig. 3c ). Aw112010 was significantly upregulated by LPS, and because it was identified as protein coding by RRS, translational efficiency, RibORF and RiboCode analysis, we choose to investigate this non-canonical ORF further. Overexpression of the Aw112010 ORF in HEK293 cells demonstrated robust protein expression and distinct subcellular localization (Fig. 2f) , whereas overexpression of other identified ORFs, Gm9895 and Gm7160, showed strong vesicular localization and predominantly cytoplasmic staining (Extended Data Fig. 4 ). As such overexpression systems are artificial and cannot definitively establish real translation of an ORF in its natural context, we wished to determine whether translation of Aw112010 occurs endogenously in response to LPS. As no antibodies exist for this uncharacterized ORF, we generated an epitope-tagged Aw112010 mouse. RRS analysis for Aw112010 identified the native translation termination codon, and using a guide RNA that targeted this locus and a donor single-stranded DNA (ssDNA) template, we successfully introduced a C-terminal haemagglutinin-epitope tag into the Aw112010 gene in mice using CRISPR-Cas9 technology (Extended Data Fig. 5a -c).
Generation of BMDMs from wild-type and Aw112010
HA mice revealed that the Aw112010 'lncRNA' does in fact generate a stable protein in response to LPS even 24 h after stimulation (Fig. 2g) . We next sought to characterize in more detail the haemagglutinin-tagged protein observed in the Aw112010 HA macrophages. To enrich for the endogenous protein, we stimulated Aw112010 HA BMDMs for 6 h with LPS, and cell lysates were generated and subjected to antihaemagglutinin immunoprecipitation (Extended Data Fig. 5d ). Aw112010 HA -purified fractions were subjected to mass spectrometry 23 . Endogenous Lys-C protease-digested peptides mapped uniquely to the predicted Aw112010 ORF-encoded protein with more than 50% total protein coverage (Extended Data Fig. 6a, b) . Furthermore, we validated one of the peptide assignments with an isotopically labelled standard (labelled with 15 N 2 13 C 6 -lysine at the C-terminal residue), which showed co-elution and co-fragmentation with the unlabelled endogenous peptide from the stimulated Aw112010 HA macrophage proteome ( Fig. 2h and Extended Data Fig. 6c ). Together, these data indicate that noncanonical ORFs can generate abundant and stable proteins that exhibit discrete subcellular localizations. Furthermore, we demonstrate that Aw112010 is a bona fide non-canonical ORF protein-coding gene that is translated during the innate immune response to bacterial infection.
To investigate whether the translation of the non-canonical ORF within Aw112010 was physiologically important in the immune response, we generated Aw112010
Stop knock-in mice. We used CRISPR-Cas9 technology to insert a small frameshifting stop cassette sequence into an area of high ribosomal occupancy to abrogate its protein-coding potential (Extended Data Fig. 7a-d ). Because bacterial infection can induce robust translation of Aw112010, we infected wild-type and littermate Aw112010
Stop mice with 1 × 10 3 colony forming units (CFUs) of S. Typhimurium via oral gavage. Aw112010 Stop mice displayed accelerated weight loss compared to wild-type littermates (Fig. 3a) . Indeed, disruption of the Aw112010 ORF resulted in increased faecal CFUs 24 h after infection (Fig. 3b) . Similarly, mice euthanized 4 days after infection showed increased bacterial load in the caecum of Aw112010 stop mice (Fig. 3c) . Furthermore, Aw112010
Stop mice presented with higher bacterial burden and dissemination to the liver and spleen than wild-type littermates (Fig. 3d, e) . In addition, when Aw112010 Stop mice were infected with 1 × 10 2 CFUs of S. Typhimurium, they displayed accelerated bacterial dissemination and became moribund with bacterial infection significantly quicker than wild-type mice (Fig. 3f, g ). To investigate whether Aw112010 also contributed to mucosal auto-inflammatory disorders such as models of inflammatory bowel disease, we administered 2.5% dextran sulfate sodium (DSS) to the drinking water of wild-type and Aw112010
Stop Stop cohoused littermate mice were administered 2.5% DSS in their drinking water for 5 days. h, Weight loss from wild-type (n = 11) and Aw112010 Stop (n = 12) mice was measured over 12 days. i, Colon length was measured from wild-type (n = 10) and Aw112010 Stop (n = 12) mice. Horizontial bars in b-e represent the mean bacterial count. Error bars in h and i denote s.e.m. of replicates. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, nonparametric Mann-Whitney test (b-e), log-rank test (g), and unpaired two tailed t-test (a, h, i). Stop mice were significantly protected from colitis as measured by weight loss and colonic shortening compared to wild-type counterparts (Fig. 3h, i) . Together, these data demonstrate that the translation of the non-canonical ORF in Aw112010 is required for the mucosal inflammatory response.
We next sought to determine the mechanism by which Aw112010 mediates its anti-bacterial and pro-inflammatory function in BMDMs. Wild-type and Aw112010 stop BMDMs showed no difference in their ability to phagocytose or initiate phagosome acidification of pHsensitive bacterial BioParticles (Fig. 4a) . Similarly, intracellular killing or survival of S. Typhimurium was also comparable between wild-type and Aw112010
Stop BMDMs (Fig. 4b) . Furthermore, the ability of wild-type and Aw112010
Stop cells to undergo the inflammatory cell death pathway, pyroptosis, was unaltered in Aw112010
Stop macrophages compared to wild-type counterparts (Fig. 4c) . We next investigated whether Aw112010 was essential for the production of known cytokines responsible for anti-Salmonella defence and that contributed physiologically to the intestinal inflammation and inflammatory bowel disease. Notably, although wild-type BMDMs were able to generate a robust LPS induction of IL-12p40 and IL-6, Aw112010
Stop macrophages showed a significant deficiency in their production, whereas the release of anti-inflammatory IL-10 was unaltered in Aw112010
Stop macrophages ( Fig. 4d and Extended Data Fig. 8a-c) . To confirm this in vivo, wild-type and Aw112010
Stop mice were administered LPS by intraperitoneal injection and serum was collected after 6 h. Again, wild-type animals were able to induce a robust IL-12p40 and IL-6 response that was significantly curtailed in Aw112010 stop mice ( Fig. 4e and Extended Data Fig. 8d) . Notably, patients with deficiencies in IL-12R are characterized by severe and recurrent Salmonella infections, and mice deficient in the IL-12p40 cytokine subunit are also susceptible to S. Typhimurium challenge 24, 25 . Furthermore, IL-12p40 has a crucial role in inflammatory bowel disease, and a neutralizing monoclonal anti-IL12p40 antibody has been shown to be an efficacious treatment in patients with Crohn's disease and in experimental models of colitis 26, 27 . The introduction of a stop codon into Aw112010 causes a major defect in IL-12p40 production and in the ability of mice to combat Salmonella infection and undergo mucosal inflammation. However, as premature stop codon introduction into a protein-coding gene can lead to nonsensemediated decay 28 , we investigated this phenomenon in Aw112010 Stop macrophages. Notably, premature stop codon insertion into Aw112010 does trigger nonsense-mediated decay that can be rescued with the administration of cycloheximide or a specific nonsense-mediated decay inhibitor 29 ( Fig. 4f, g ). Although this demonstrates the vital importance of translation for Aw112010 gene expression, it presents a problem in that we cannot distinguish a potential lncRNA function from a potential protein function. To this end, we generated an expression plasmid that contained the wild-type Aw112010 ORF transcript and an extensively mutated transcript with synonymous nucleotide substitutions in all codons except the CTG start codon. As expected, these RNAs display a very different folding behaviour, but they generate the same protein product (Fig. 4h and Extended Data Fig. 9a-c) .We could successfully reintroduce Aw112010 protein expression in Aw112010
Stop BMDMs with nuclear electroporation (Fig. 4i) . The loss of IL-12p40 expression and release of this cytokine were almost completely restored with both the wild-type and mutated Aw112010 expressing rescue plasmids ( Fig. 4j and Extended Data Fig. 9d) . Together, our data provide clear evidence that the ability of Aw112010 to drive IL-12p40 production is dependent on the non-canonical ORF-encoded protein and does not act as its lncRNA annotation dictates.
We demonstrate that the translation of functional non-canonical ORFs is a crucial event during the innate immune response to infection and inflammation. A considerable fraction of non-coding RNA genes 
Plots are representative of three independent experiments. b, BMDMs were infected with S. Typhimurium for 6 h. Cells were lysed and CFUs were determined. c, BMDMs were pretreated with LPS (100 ng ml −1 ) for 5 h and infected with S. Typhimurium for 1 h, and the release of lactate dehydrogenase (LDH) was measured. RU, relative units. d, BMDMs were stimulated with LPS (10 ng ml −1 ), and Il12b expression was determined by qPCR. e, Mice were administered PBS (n = 5) or LPS (n = 6, WT and Aw112010
Stop ) (10 mg kg −1 ) for 6 h via intraperitoneal injection. Serum levels of IL-12p40 were determined by ELISA. f, BMDMs were stimulated with LPS (10 ng ml −1 ), and Aw112010 expression was determined by qPCR. g, BMDMs were treated with cycloheximide (CHX; 50 μg ml −1 ) or nonsense-mediated decay inhibitor (iNMD; 50 μM) for 6 h, and Aw112010 expression was determined by qPCR. Fold change was determined relative to vehicle samples. h, Predicted minimal free energy of RNA folding of wild-type and mutant (Mut) Aw112010 mRNA. i, j, BMDMs were subjected to electroporation with indicated plasmids. BMDMs were stimulated with LPS (10 ng ml −1 ) for 6 h. i, Western blot conducted for Aw112010-Flag and β-tubulin. j, Il12b mRNA was determined by qPCR. Error bars denote s.e.m. Data in b and c are from three independent experiments conducted with three biological and three technical replicates. Data in d are from three biological replicates, and fold change in expression was calculated relative to the non-treated wild-type sample. Data in f and g are from four independent experiments. Data in i and j are from three biological replicates. Fold expression in j is calculated from a single wild-type EV NT replicate for wild-type cells, and a single Aw112010
Stop EV NT replicate for Aw112010 Stop cells. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, unpaired two-tailed t-test. Letter reSeArCH not only associate with the ribosome, but also undergo active protein translation. Although we have only shown this in mouse macrophages, it is highly likely that the same will hold true for most cells and tissues in other eukaryotes. Notably, we have demonstrated the translation of one of these ORFs, and the protein it encodes is functional and has a crucial role in host defence and inflammatory disease. Further work is ongoing to uncover the roles of the other identified non-canonical ORFs. We propose that a re-evaluation of the human protein-coding genome is required to identify cryptic non-canonical ORF protein products that may have major implications for human health and disease.
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Letter reSeArCH MEthodS Mice. RiboTag (B6N.129 strain) and LysM-Cre (B6.129P2 strain) mice have previously been described and were obtained from Jackson Laboratories 6, 7 . Crossing these mice facilitates the inclusion of a HA-epitope tag on the ribosomal protein RPL22 in all LysM-expressing cells, such as BMDMs and colonic macrophages. Aw112010
HA and Aw112010 Stop mice were generated as previously described with CRISPR-Cas9 technology 30 into C57/B6N embryos. To generate Aw112010 HA mice, a ssDNA donor oligonucleotide containing a flexible linker sequence followed by an HA epitope tagsequence flanked with homology arms was provided to facilitate homology-directed repair insertion of the sequence into the C terminus of the Aw112010 ORF. In brief, a guide R NA ( A GA AG GA AG AG GA CT TA TT T GT TT TA GA GC TA GAAATAGCAAGTTAAAATA AG GC TA GT CC GT TA TC AA CT TG AA AA AG TG GC AC CGAGTCGGTGCTTTTTT) (bold sequence represents guide RNA sequence targeting gene) and ssDNA Ultramer (IDT) donor t em pl ate ( AA CC TC AA GT GG AA AA AG CC AC CC AC TG GG TC GT TC AG GA GA GA TC CA GT CT TT AA AG AA GC AA AACggtggttctggtggtggttctggtg gtggttctggttacccatacgatgttccagattacgctTAGAGAgCAAAATAAGTCCTCTTCCT TCTAGATGTGCATCATCTGCTTCTTCCTTCCCTAGAAGACT) (lowercase sequence represents the knock-in cassette; uppercase sequence represents homology arms) were designed targeting the exon 3 stop codon locus of Aw112010 to generate Aw112010 HA mice. To generate Aw112010 Stop knock-in mice, CRISPR-Cas9 technology was used to introduce a double-stranded DNA in the second exon of the transcript, in area of high ribosomal protection. A ssDNA donor oligonucleotide containing a small 14-nucleotide sequence (TAATTAATTAATTA) sequence flanked with homology arms was provided to facilitate homology-directed repair insertion into the ORF. This sequence contains a stop codon in all three frames and owing to its even number of nucleotides, it will also frameshift any protein-coding sequence upon insertion. A guide R NA ( C TG CC TG AT GC AA CA AT AC C GT TT TA GA GC TA GA AA TA GC AA GT TA AA AT AA GG CT AG TC CG TT AT CA ACT TGAAAAAGTGGCACCGAGTCGGTGCTTTTTT) (bold sequence represents guide RNA sequence targeting gene) targeting exon 2 of Aw112010 was designed and co-injected into fertilized C57/B6N eggs with a ssDNA Ultramer (IDT) donor template ( TCCTATTCATCTGATCTGCTTCCAGATCCCTCTGATATTTATC TTTGGTGGTGTGCTCATCATCTGCCTGATGCAAtaattaattaattaCAATACCTG GCGTATAAGTCTTCTAAGAACGTCGTTAAAGTCTTCTGCCATCAAGCC AATGATGTGAGTGCTGGG) (lowercase sequence represents the knock-in cassette; uppercase sequence represents homology arms) containing a frameshifting stop insertion and 2 homology arms to allow for homology-directed-repairmediated genomic integration to generate A112010
Stop codon knock-in mice. Single heterozygous founder mice were generated and backcrossed to C57/B6N mice. Experimental groups of wild-type and Aw112010
Stop knock-in mice were generated by heterozygote-by-heterozygote breeding. All experiments were performed using littermate control, cohoused mice. All mice experimentation was performed in compliance with Yale Institutional Animal Care and Use Committee protocols. No formal blinding or randomization was conducted; however, control and treated groups were chosen arbitrarily for each experiment. Samples sizes were chosen in line with pervious experimental experience and consistent with the broader literature. Mice weights and CFUs were measured in a blinded manner.
RiboTag
LysM macrophage RNA isolation and processing. BMDMs were generated from progenitor cells isolated from the femurs and tibias of RiboTag LysM mice and maintained in macrophage-colony stimulating factor (50 ng ml −1 ) for 7 days. Cell were stimulated with LPS (serotype O111:B4) at the indicated concentrations and times. BMDMs were infected in antibiotic free media with 1 MOI of S. Typhimurium for 1 h. Cells were then treated with gentamycin (100 μg ml ) to kill extracellular bacteria and incubated for a further 5 h before collection. Cells were washed in ice-cold PBS twice, and then RiboTag lysis buffer (containing cycloheximide, heparin and the RNase inhibitor SuperaseIN) was added directly to the cells on ice as previously described 6, [31] [32] [33] . Cell lysates were passed through a 26-gauge needle 10 times and incubated for 30 min on ice to ensure complete lysis. For intestinal macrophage ribosome isolation, control and S. Typhimurium infected mice were fasted for 4 h and administered streptomycin (20 mg per mouse) by oral gavage. After 20 h, mice were again fasted for 4 h and gavaged with (2 × 10 8 CFUs of S. Typhimurium. After 24 h, mice were euthanized and the colons were removed. After washing and flushing with PBS, the colon was separated into five equal-sized samples and placed into 1 ml of RiboTag lysis buffer each. Tissue was lysed in a three-step manner. First, tissue was mechanical disrupted with an electronic tissue homogenizer for 30 s. Then homogenized tissue was further processed in a Dounce homogenizer with 10 strokes. Finally, colon lysates were passed through a 26-gauge needle 10 times and incubated on ice for 30 min. Ribosome-RNA-containing supernatants were clarified by centrifugation at 12,000g for 10 min at 4 °C. Haemmaglutinin-conjugated magnetic beads (Pierce) were added to samples and incubated overnight under gentle inversion at 4 °C. Beads were washed three times for 10 min with gentle rotation in high-salt buffer containing cycloheximide. RNA was eluted from HA-beads using Qiagen RLT buffer containing 2-Mercaptoethanol and anti-foaming DX reagent (Qiagen) by 30 s vortex pulsing. RNA was isolated using an RNAeasy micro kit. RNA was sent for sequencing or converted to cDNA using Maxima Reverse transcriptase kit (Thermo). qPCR using Sigma KiCqStart predesigned SYBR green primers was conducted. mRNA for RNA-seq analysis was purified using poly(A) + selection and processed by the Yale Centre for Genome analysis using standard methodology. RNA was sequenced on a HIseq2000 with 75-bp paired-ended reads. RiboTag RNA-seq analysis. Fastq files from RNA-seq and RiboTag RNA-seq were aligned to the Ensemble GRCm38.p5 genome using Tophat2 version 2.1.1, and using a gene annotation file which combined all RefSeq, UCSC, Ensembl, Gencode and mirBase annotations for full genome coverage. Remaining missing annotations were added manually from MGI. Cufflinks version 2.2.1 was used for differential analysis. A cut-off of FPKM ≥ 0.1 was used in the RNA-seq to define a 'detectable' lncRNA, and a cu-toff of FPKM ≥ 1 in at least one of the three ribotag-RNA-seq treatments was defined as an 'expressed' lncRNA. featureCounts of the Subread package was used to determine reads per feature in the genome 34 , which was then used with DEseq2 and ggplot2 (http://ggplot2.tidyverse.org/index.html) to produce volcano plots 35 . RCircos was used to make a circos plot showing the RiboTag RNA-seq data 36 , using a differential cut-off of 0.01. Only reads which aligned to a single genome locus were used. Macrophage ribosome profiling and analysis. BMDMs were generated and plated at 1 × 10 7 cells per treatment group. Non-treated and LPS stimulated macrophages were treated with cycloheximide (50 μg ml ). Ribosome profiling was conducted using the illumina TruSeq Ribo Profile (mammalian) Kit as per manufacturer's instructions. Prepared libraries were sequenced with a HiSeq 2000 with 75-bp single end reads. In tandem, total RNA from paired samples were subjected to Ribosomal RNA removal and convention RNA-seq. Reads from ribosome profiling experiments had their adapters trimmed using the FASTXToolkit version 0.0.14 (http://hannonlab.cshl.edu/fastx_toolkit/index.html). Reads were aligned to Ensemble GRCm38.p5 genome using Tophat2. The accepted hits were filtered using Samtools version 1.5 (http://samtools.sourceforge.net/) along the criteria of having an alignment score of 0 to −2, and the number of possible alignments in the genome being less than or equal to 2 to reduce false alignments to repeat regions. Cufflinks was then used for differential expression. DESeq2 and ggplot2 were used for making volcano plots. Sushi and ggplot2 were used to build RNA-seq and ribosome profiling coverage plots for certain features 37 . A pipeline to determine the translation efficiency and RRS included finding the number of reads covering each feature using featureCounts. Protein coding gene annotations and their UTRs were extracted from our larger GTF annotation file. mRNA sequences from lncRNA exons were extracted using Bedtools version 2.26.0 38 . To identify non-canonical ORFs in lncRNAs, we first catalogued all transcripts that harboured high quality and unique ribosome profiling reads mapping to exons in the annotated lncRNA family. We then conducted a custom ORFfinder search, in which we relaxed ORF identification parameters pertaining to ORF size and start codon utilization. NCBI ORFfinder and the Sequence Manipulation Suite ORF Finder tools were used to find all ORFs more than 30 nucleotides long using start codons ATG, CTG, TTG and GTG 20 . Found ORFs were searched using BLASTX+ version 2.6.0 against lncRNA sequences that included their introns to find the final position of ORFs within the lncRNAs. UTRs were defined as 50 nucleotide bases directly following the coding sequence. Translational efficiency and RRS were calculated according as previously described 3 . Translational efficiency was the number of ribosomal reads covering the exons divided by the number of RNA reads in the exon, normalized for length. In brief, RRS interrogates the known phenomenon of ribosome release from a transcript directly after recognition of the ORFs cognate stop codon 39 by enumerating the number of ribosome profiling reads before and after the in frame stop codon of a given mRNA. RRS is the result of ribosomal reads covering the exon divided by RNA reads covering the exon, divided by the result of ribosome reads covering the 3ʹ UTR divided by RNA reads covering the 3ʹ UTR. RRS ≥ 7 and translational efficiency ≥ 0.0001 values are considered that of the annotated protein coding genome. Exons had to have at least 1 ribosomal read for these metrics to be calculated. A FPKM cut-off of ≥ 4 in either treatment was used when identifying top significant differentially regulated features. Significance of P < 0.05 was used. RibORF version 0.1 was used identify transcripts undergoing active translation measured by the correct alignment of the ribosome A-site, 3-nucleotide periodicity of translating ribosomes and coverage uniformity across all codons of protein coding genes. RibORF was then used to assign PME scores to the OFRs found with ORFfinder. A PME above 0.6 was used to predict positive coding potential. RiboCode version 1.2.10 was used to identify ORFs within the ribosome profiling data using start codons ATG, CTG, TTG and GTG. A combined analysis P < 0.05 was used to determine protein-coding potential. The nucleotide sequences of all predicted coding ORFs found were searched for homology in the human CHESS 2.0 genome (http://ccb.jhu.edu/chess/) using BLASTX+ version 2.6.0. PhyloCSF was used on the top hit of ORFs for which homology was found Letter reSeArCH to further assess coding potential 40 . All lncRNA RNA sequencing and analysis is provided in Supplementary Table 1 . Expression of non-canonical ORFs. Gene blocks corresponding to the open readings identified by ribosomal profiling were synthesized by IDT and inserted into pCMV6-entry tagged cloning vector (PS100001) using MLU I and Sgf I restriction digestion. Plasmids were verified by Sanger sequencing and propagated by transformation in TOP10 competent cells. HEK293 cells were transfected using Transit LT1 liposomal transfection reagent (Mirus) as per manufacturer's instructions. For confocal microscopy studies, HEK293 (obtained directly from ATCC) cells were transfected with 0.5 μg of plasmid DNA and incubated at 37 °C for 24 h. Cells were fixed in methanol. Anti-Flag monoclonal antibody (M2 clone), phalloidin 647 (Santa Cruz) and DAPI (Sigma) were used. Confocal imaging was conducted with a Nikon-Ti microscope combined with UltraVox spinning disk (PerkinElmer) and data was analysed using the Volocity software (PerkinElmer). Cells were not tested for mycoplasma and were not further authenticated.
Aw112010
HA immunoblotting and immunoprecipitation. Wild-type and Aw112010
HA BMDMs were generated and treated with LPS (10 ng ml
) for the indicated times. Protein lysates and haemagglutinin immunoprecipitation fractions were generated using the Pierce HA-Tag Magnetic IP/Co-IP Kit as per manufacturer's instructions. Protein lysates and haemagglutinin immunoprecipitation samples were resolved on NuPAGE 4-12% Bis-Tris protein gels using MES running buffer (Invitrogen) and transferred to nitrocellulose membrane. Detection of endogenous Aw112010 was conducted using a monoclonal anti-HA antibody (HA1.1 clone) and β-tubulin (E7 clone) was used as a loading control. ) for 6 h were lysed and subjected to haemagglutinin immunoprecipitation as described above. An aliquot of haemagglutinin-purified protein lysate was boiled for 15 min in 1% SDS followed by chloroform-methanol precipitation 41 . Reduction, alkylation, and Lys-C protease digestion were performed according to standard protocols 42, 43 . All resulting peptides were purified and desalted using a SepPak Classic SPE cartridge (Waters) according to the manufacturer's instructions and dried in a rotary vacuum centrifuge. Samples were resuspended in 0.1% trifluoroacetic acid and diluted to approximately 0.5 μg μl −1 . Peptide standards (JPT Peptide Technologies) with 13 C 6 15 N 4 R isotopic labels were added to a 100 ng ml −1 final concentration 44 . A total volume of 5 μl of sample was injected onto an analytical column (75 μm × 50 cm PicoFrit column packed with 1.9 μm ReproSil-Pur 120Å C18-AQ resin) using ACQUITY UPLC M-Class (Waters) and a Q Exactive Plus (Thermo). Separation was performed on a 330 min nonlinear gradient from 1% mobile phase B to 99% mobile phase B (mobile phase A: 1% acetonitrile 0.1% formic acid in water, mobile phase B: 80% acetonitrile 0.1% formic acid in water); MS: 70,000 resolution, 3 × 10 6 AGC target, 300-1,700 m/z scan range; dd-MS2: top10 method, 17,500 resolution, 1 × 10 6 AGC target, 10 loop count, 1.6 m/z isolation window, 27 normalized collision energy. In all experiments, a full mass spectrum was followed by ten parallel reaction-monitoring scans at 17,500 resolution 2 × 10 5 AGC target, 4 m/z isolation window 100 ms maximum injection time) as triggered by an inclusion list. ProteoWizard MS Convert was used for peak picking and files were analysed using Mascot (version 2.5.1). RNA-seq data from LPS and nontreated mouse macrophages were aligned to Ensemble GRCm38.p5 genome and translated in three reading frames using CLC SequenceViewer (Qiagen) and the resulting databases as well as a contaminant database were used for proteomics searches. Carbamidomethyl (C) was set as a fixed modification, and 13 C 6 15 N 4 R, oxidation (M), and acetyl (N-term) as variable modifications. The false discovery rate was set to 1%. S. Typhimurium infection. Before infection, 8-10-week-old mice were restricted from food and water for 4 h followed by gavage of streptomycin (20 mg). After 20 h, mice were fasted again for 4 h and infected with streptomycin resistant Salmonella enterica subsp. enterica serovar Typhimurium (SL1344 strain, provided by J. Galan). S. Typhimurium was maintained as a glycerol stock at −80 °C. Before infection, bacteria were propagated overnight in LB containing streptomycin (100 μg ml
−1
). Bacteria was subcultured for 4 h the next day in antibiotic-free LB containing 0.3 M NaCl to return it to log phase growth and increase virulence 45 . Using spectrophotometry, bacterial CFU was calculated with an infection dose ranging from 1 × 10 2 to 1 × 10 3 CFUs per mouse. To calculate faecal CFU, faecal pellets were resuspended in PBS at 50 mg ml −1 and vortexed for 20 min. Bacteria containing supernatants were clarified by centrifugation at 50g for 10 min. Serial dilutions were conducted, and bacteria plated in triplicate on LB streptomycin (100 μg ml −1 ) plates. For caecal, liver and spleen CFU enumeration, organs were isolated and weighed, and added to 2 ml of PBS. Tissue was dissociated with GentleMacs C Tubes (Miltenyi Biotech) as per manufacturer's instructions. CFU counts were calculated using similar methodology as above. All CFU counts were preformed blinded. Mice that lost 30% body weight, or that were unresponsive, were euthanized. Confocal microscopy for splenic Salmonella dissemination. Wild-type and Aw112010
Stop codon mice were infected with 1 × 10 2 CFUs as described above.
Mice were euthanized 3 days after infection. For in situ immunofluorescence, spleens were dissected, fixed in 4% paraformaldehyde for 1 h at 4 °C, followed by incubation in 10% sucrose in PBS for 1 h, 20% sucrose in PBS for 1h, and 30% sucrose in PBS overnight at 4 °C, all under gentle agitation. Tissue samples were frozen in OCT on dry ice and kept at −80 °C until sectioning. Sections 8-10-μm thick were prepared with a cryostat (Leica). Spleen sections were permeabilized with Perm/Wash buffer (BD Biosciences) for 10 min and blocked with Protein Block (Dako) for 7 min. Primary antibodies included anti-F4/80 (BM8), anti-B220 (RA3-6B2) and anti-Salmonella (Abcam ab35156). Primary and secondary antibodies were incubated in Perm/Wash buffer for 1 h. After washing with Perm/Wash buffer, sections were mounted with ProLong Gold with DAPI (Invitrogen), covered and sealed with nail polish. Confocal imaging was conducted with a Nikon-Ti microscope combined with UltraVox spinning disk (PerkinElmer) and data was analysed using the Volocity software (PerkinElmer). DSS colitis induction. DSS colitis was conducted as previously described 30 . In brief, 10-12-week-old mice were administered 2.5% DSS (MP Bio) for 5 days and returned to regular drinking water and monitored daily. Weight loss was measured every day. On day 12, mice were euthanized and colons were extracted. Colonic shortening was used as a metric of colitis severity. Phagocytosis assay. Wild-type and Aw112010
Stop BMDMs were generated and plated on non-tissue culture-treated non-adherent plates and pretreated with the phagocytosis inhibitor cytochalasin D (10 μM) for 1 h, LPS (10 ng ml −1 ) for 6 h or left non-treated. Cells were then administered with 1 mg ml −1 pHrodo Red Escherichia coli BioParticles (Invitrogen) conjugates for 1 h. Cells were isolated, washed and stained with anti-CD11b (M1/70). CD11b positive cells were assessed for pHrodo positivity which indicates cells which have phagocytosed the pH sensitive bio particles and initiated phagosome acidification using a LSRII flow cytometer. Intracellular Salmonella survival assay. Wild-type and Aw112010
Stop BMDM generation and S. Typhimurium bacterial culturing was conducted as previously described. On day 7, the BMDM culture media was replaced with antibiotic-free media. BMDMs (1 × 10 6 ) were infected in triplicate with 1 × 10 7 CFUs of S. Typhimurium (MOI 10) by centrifugation at 800g at 37 °C for 10 min and returned to the incubator for a further 20 min. Media was then removed and replaced with media containing gentamycin (100 μg ml Stop BMDMs were generated and seeded at 50,000 cells per 96 well plate in triplicate. Cells were stimulated with LPS (100 ng ml ) and S. Typhimurium (MOI 100). Cells were centrifuged at 800g at 37 °C for 10 min. Cells were returned to the incubator for a further 50 min. Supernatants were collected and clarified. The Pierce LDH Cytotoxicity Assay Kit was used to measure cell death, as per manufacturer's instructions. In vitro BMDM LPS-induced cytokine measurement. Wild-type and Aw112010
Stop BMDMs were generated and stimulated with LPS (10 ng ml
) for the indicated times. Supernatants were collected and clarified by centrifugation (12,000g, 10 min at 4 °C) and analysed for IL-12p40, IL-6 and IL-10 by ELISA (R&D Duosets). Similarly, BMDMs were generated and stimulated as above and lysed in Trizol and RNA extracted as per manufacturer's instructions. RNA was equalized to 700 ng and converted to cDNA using Maxima Reverse transcriptase kit (Thermo). qPCR was conducted using Sigma KiCqStart predesigned SYBR green primers as indicated. In vivo LPS-induced cytokine measurement. Wild-type and Aw112010 ) via intraperitoneal injection. After 6 h, mice were euthanized and serum collected and analysed for IL-6 and IL-12p40 cytokines by ELISA (R&D Duosets). Nonsense-mediated decay studies. Wild-type and Aw112010
Stop BMDMs were generated and stimulated with cycloheximide (50 μg ml ) or a nonsensemediated decay inhibitor (Calbiochem) (50 μM) for 6 h. RNA was extracted and qPCR conducted for Aw112010 mRNA expression. RNA and protein structural prediction tools. Two Aw112010 rescue expression plasmids were generated. The wild-type Aw112010 mRNA sequence was cloned into the pCMV6 expression vector: CTGAGCTGCAAGATGTCTCCCATCCCTCTGATATTTATCTTTGGTGG TGTGCTCATCATCTGCCTGATGCAACAATACCTGGCGTATAAGTCTTCTA AGAACGTCGTTAAAGTCTTCTGCCATCAAGCCAATGATGTACATATATA CCAGACCCAGGTCGTCATGACAAACACACTGGAAACCTCAAGTGGAAA AAGCCACCCACTGGGTCGTTCAGGAGAGATCCAGTCTTTAAAGAAGC AAAAC.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Confocal Imaging was analysed using Velocity Software as indicated in the methods. Circos Plots were generated using CircosR as described in the methods All graphing and associated statistical analysis was performed using GraphPad Prism 7. Bioinformatic anlaysis was conducted using the following tools and versions: Cufflinks/2. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials 8. Materials availability Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company. 
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Anti-Flag, M2 Clone, Sigma # F1894. Phalloidin-647, Santa Cruz # sc-363797 B-tubulin E7 Clone, DHSB. DAPI, Sigma # 10236276001. anti-ha beads, #88837, thermo. Anti-Ha, HA.11, biolegend, #901503. anti-F4/80, BM8, Biologend. antib220,RA3-6B2, Biolegend. anti-salmonella, ab35156, abcam.
All common antibodies used consistent with the literature and data sheets.
